PARATEK PHARMACEUTICALS INC shareholders Q1 2023

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

PARATEK PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Arete Wealth Advisors, LLC 14,050$360.00%
WATER ISLAND CAPITAL LLC 13,050$330.00%
B. Riley Wealth Advisors, Inc. 30,000$76,2000.00%
TWO SIGMA ADVISERS, LP 273,300$694,1820.00%
ACADIAN ASSET MANAGEMENT LLC 139,386$3520.00%
ETF MANAGERS GROUP, LLC 18,339$46,5810.00%
GABELLI FUNDS LLC 34,500$87,6300.00%
Renaissance Technologies 242,124$6150.00%
Baader Bank Aktiengesellschaft 11,580$22,9410.00%
D. E. Shaw & Co., Inc. 353,499$897,8880.00%
Kingsview Wealth Management, LLC 10,000$25,4000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 33,812$85,8820.00%
GEODE CAPITAL MANAGEMENT, LLC 466,795$1,185,6590.00%
WELLS FARGO & COMPANY/MN 22,034$55,9660.00%
STATE STREET CORP 226,010$574,0650.00%
MILLENNIUM MANAGEMENT LLC 71,470$1820.00%
BANK OF AMERICA CORP /DE/ 58,918$149,6520.00%
GAMCO INVESTORS, INC. ET AL 15,500$39,3700.00%
HARBOUR INVESTMENTS, INC. 2$50.00%
External links

This page lists PARATEK PHARMACEUTICALS INC's shareholders in Q1 2023. To view PARATEK PHARMACEUTICALS INC's shareholder history, click here.